Initial default among diagnosed sputum smear-positive pulmonary tuberculosis patients in Andhra Pradesh, India

B Sai Babu1, A V V Satyanarayana, G Venkateshwaralu

  • 1Department of Health, State Government of Andhra Pradesh, Hyderabad, Andhra Pradesh, India. drsaibabu@yahoo.co.in

Insights

Nearly 5% of smear-positive pulmonary tuberculosis (PTB) patients in India did not initiate treatment. Improving address recording and patient counseling are crucial to reduce initial treatment default in the Revised National TB Control Programme (RNTCP).

Area of Science:

  • Public Health
  • Infectious Diseases
  • Tuberculosis Control

Background:

  • The Revised National TB Control Programme (RNTCP) in India defines 'initial defaulters' as smear-positive pulmonary tuberculosis (PTB) patients not confirmed to have started treatment.
  • Understanding the reasons for treatment non-initiation is critical for improving TB control program effectiveness.

Purpose of the Study:

  • To investigate the reasons behind treatment non-initiation among smear-positive PTB patients identified as initial defaulters under the RNTCP.
  • To assess the magnitude of initial default in a specific region of India.

Main Methods:

  • A cross-sectional survey was conducted in twenty districts of Andhra Pradesh, India.
  • The study included all patients reported as initial defaulters between July and September 2006.
  • Data collection involved verifying treatment status and identifying reasons for non-initiation.

Main Results:

  • Out of 1304 reported initial defaulters, 47.5% were incorrectly reported, often due to poor documentation or delayed treatment initiation.
  • Among the confirmed 685 initial defaulters (4.5% of total diagnosed), 51% were untraceable, 22% had died before treatment, and 13.5% cited other reasons like refusal.
  • A significant proportion of initially reported defaulters were actually initiated on treatment, highlighting documentation issues.

Conclusions:

  • Approximately 5% of diagnosed smear-positive PTB patients failed to initiate treatment under the RNTCP during the study period.
  • Improving patient address recording systems is essential for patient retrieval and treatment adherence.
  • Further research is needed on enhancing patient counseling to prevent initial default and understanding mortality before treatment initiation.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...